Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1864663 (
HCC
)
2,985
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Experiments were done to determine the effect of interleukin-1-beta (
IL-1 beta
) on metastasis formation in different tumor systems. Intravenous administration of 1 microgram of human recombinant
IL-1 beta
given 1 hour before tumor cell injection augmented lung colony formation (experimental metastases) by the human A375 melanoma variants, the human HT-29M colon carcinoma, the SN12-K1 renal carcinoma in nude mice, the murine B16 melanoma variants, and the murine UV-2237M fibrosarcoma in syngeneic recipients. The same treatment did not induce lung colony formation by a human rectal carcinoma (
HCC
-P2988) or by a murine reticulum cell sarcoma (M5076), both of which are not metastatic to the lung. Spontaneous metastases were studied in C57BL/6 mice bearing the B16-BL6 melanoma (metastatic to the lung) in their footpad and the M5076 reticulum cell sarcoma (metastatic to the liver) subcutaneously. Daily intraperitoneal treatment with 1 microgram of
IL-1 beta
increased lung and liver metastases. These findings indicate that treatment of mice with
IL-1 beta
can increase the number of artificial or spontaneous metastases and that this effect is not limited to a single tumor type or to a specific organ.
...
PMID:Effect of interleukin-1-beta on metastasis formation in different tumor systems. 198 86
To examine the effects of polymorphisms in the gene encoding proinflammatory interleukin (IL)-1beta in patients infected with hepatitis C virus (HCV) in Japan, we studied 364 patients with chronic HCV infection (146 of whom had hepatocellular carcinoma [
HCC
] and 218 of whom did not) and 230 healthy control subjects.
IL-1B
-511 and IL-1RN genotypes were ascertained, and
IL-1B
-511 genotype T/T was found to be significant risk factors for the development of
HCC
, indicating that polymorphism in the
IL-1B
-511 genetic locus is one of the possible determinants of progression of hepatitis C to
HCC
.
...
PMID:Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan. 1275 Oct 42